JPRN-jRCT2080220301未知3 期
Confirmatory study of TA-8317 in patients with cancer breakthrough pain Open-label, crossover, comparative study using a comparator, morphine used as rescue medication
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(Inclusion criteria)
- •Patients who are 20 years old or older.
- •Patients who are diagnosed and notified to have cancer.
- •Patients who are treated for persistent cancer pain with opioid analgesics and whose breakthrough pain is controlled with rescue morphine administration , etc.
- •(Exclusion criteria)
- •Patients with pain that is difficult to control with opioid analgesics.
- •Patient's performance status scale (PS) is grade 4.
- •Patients with moderate to severe stomatitis , etc.
排除标准
- 未提供
研究者
相似试验
未知
3 期
A Clinical Study of TA-4708 in Patients with Chronic Atrial FibrillatioJPRN-jRCT2080221522Mitsubishi Tanabe Pharma Corporation40
未知
3 期
Z-103 Phase III Clinical Study in patients with Taste Disorder - A placebo-controlled superiority studytaste disorders induced by zinc-deficiencyJPRN-jRCT2080221862Zeria Pharmaceutical Co., Ltd.260
未知
Unknown
A confirmatory study of APTA-2217 in patients with chronic obstructive pulmonary disease (A placebo-controlled double-blind, parallel group study)JPRN-jRCT2080220095Mitsubishi Tanabe Pharma was the original trial sponsor; however Astra Zeneca is now the Responsible Party
招募中
3 期
Clinical evaluation of Diabepal tablet in comparison with Placebo tablet in Type 2 Diabetic PatientsCTRI/2014/10/005076Arjun Healthcare80
暂停
1 期
TAS0313 Phase I/II studySolid tumor (urothelial carcinoma, and so on)JPRN-jRCT2080223768Taiho Pharmaceutical Co., Ltd.130